Dermatology faculty and residents' perspectives on the dermatology residency application process: A nationwide survey
To the Editor: According to recent estimates, dermatology has the most expensive residency application process, with an approximate total cost per US senior applicant of $10,781. 1, 2 This high cost is due, in part, to the fact that dermatology has the highest median number of Electronic Residency Application Service applications submitted per US senior applicant (ie, 91). 3 We sought to examine dermatology faculty and residents' perspectives on the current residency application process, as well as identify potential modifications to the application process that are widely supported and, thus, likely to be implemented in the future.
Two anonymous, electronic surveys (1 for faculty and 1 for residents) were designed using Survey Monkey. The Oregon Health and Science University Institutional Review Board approved both surveys. The surveys were distributed nationwide via the Association of Professors of Dermatology (APD) e-mail listserv in July 2017. We collected the responses during a 3-week period; at which point, data were downloaded on Excel (Microsoft, Redmond, Washington) for analysis.
We received responses from 174 dermatology residents, and 180 out of 368 APD faculty members (48.9% response rate) (Tables I and II) . Nearly 75% of dermatology faculty recommend that applicants apply to \60 dermatology residency programs, whereas [70% of dermatology residents applied to $60 programs (Tables I and II) . Nearly 80% of both faculty and residents believe that applicants who interview via videoconferencing are not considered equally when compared with those who interview in-person. Seventy percent of faculty and [80% of residents support aims to coordinate interview dates by geographic region, and ;75% of faculty were willing to work with other programs to implement interview coordination.
The results of this nationwide survey have several important implications. First, the significant discordance between the high rate at which residents (ie, recent applicants) applied to $60 programs, despite most faculty recommending applying to \60 programs, likely reflects perceptions about the highly competitive nature of matching into dermatology. Recent Association of American Medical Colleges data indicate that there is minimal additive benefit of applying to [40 programs with respect to the outcome of matching into dermatology. 4 This data would be important to incorporate into faculty advising to reduce this gap and application costs. Second, most of both faculty and residents believe that applicants who interview via videoconferencing are not considered equally to those who interview in-person, thereby questioning the utility of offering videoconference interviews as an alternative to limit applicants' expenses. 5 Residents and faculty support the coordination of interview dates by geographic region, and most faculty are willing to work with other programs to implement this change. The coordination of interviews represents a realistic opportunity to 1) lessen applicants' expenses and stress associated with frequent travel; 2) limit programs from offering conflicting interview dates; 3) reduce interview cancellations due to weather, transportation issues, etc; and 4) decrease applicants' carbon footprint.
One important implication of this study is that the current dermatology residency application process, with its exorbitantly high cost, disadvantages applicants from lower socioeconomic backgrounds and is a barrier to applying to dermatology. Given that dermatology is also one of the least diverse specialties, second only to orthopedic surgery, 5 it should be an explicit aim of our specialty to promote inclusivity. Future qualitative studies will be important to better understand the perspectives of dermatology applicants and to identify strategies for both applicants and residency programs to lower costs and remove barriers to the application process. Believe the average total cost of the dermatology residency application process per applicant is $$10,000 18 Believe that it is acceptable for dermatology applicants to request to interview via videoconferencing to reduce their expenses
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To the Editor: In-office compounding of local anesthesia is a common practice in outpatient dermatology offices. Compounding is the process of combining $2 prescribed drugs to tailor medications to individual patient needs. Lidocaine hydrochloride 1% with epinephrine 1:100,000 represents a common anesthetic preparation. 1 Premixed lidocaine with epinephrine is acidic, so it produces significant pain upon injection. Adding 8.4% sodium bicarbonate neutralizes the pH of the solution and reduces injection pain. 2 Risks associated with pharmacy compounding have been highlighted in the media recently after a 2012 outbreak of fungal infections was linked to pharmacy compounding of methylprednisolone acetate resulting in multiple cases of meningitis. 3 The US Pharmacopeia compounding provisions establish that in-office compounding for dermatologic procedures should require sterile preparation with properly garbed personnel and near-immediate use of compounded lidocaine preparations. In outpatient settings, however, compounding typically takes place in nonsterile settings.
The type and frequency of adverse events associated with in-office compounded anesthetic injections is poorly characterized. In this study, we aim to assess the risk and character of adverse events associated with in-office compounding of local anesthesia with sodium bicarbonate in an outpatient academic dermatology facility.
We reviewed the charts of 100 randomly selected patients with biopsies performed using 1-3 mL of 1% lidocaine and 1:100,000 epinephrine compounded with 8.4% sodium bicarbonate anesthesia during January 6, 2015-March 2, 2017. Data collected included patient age, sex, date of procedure, and any adverse events within 14 days of biopsy. Only patients with clinical follow-up after the biopsy were included in our study.
The ages of patients included in our study ranged 30-93 years, with a mean age of 72 years. Male patients accounted for 66 of the biopsies, and 34 included patients were female. Out of the 100 biopsies performed, 1 adverse event was noted. Seven days after a biopsy of the left lateral sidewall of the nose, the patient complained of stinging and burning of the biopsy site. No evidence of infection was noted upon clinical exam of the biopsy site. Mohs surgery was performed on the invasive squamous cell carcinoma 2 weeks after the biopsy, and a perineural tumor was noted during the Mohs procedure.
The low number of adverse events encountered in our study supports that in-office compounding of lidocaine preparations is a safe method of providing anesthesia for dermatologic procedures. Furthermore, the adverse event encountered in our study ( paresthesia after biopsy) was more likely due to perineural invasion of the tumor than compounded anesthesia used for biopsy. 4 This retrospective chart review of patients who received anesthesia compounded in-office supports the theory that in-office compounding is a reasonable option for dermatologic procedures.
